StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) stock

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.91+0.10 (+5.52%)

Close on Nov 17, 2026Market cap $22.11MP/E –Yield –

TherapeuticsMD total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

TherapeuticsMD's total debt was $93.60M at Sep 30, 2022. For fiscal 2021 it was $188.27M, down 20.8% from the year before. The highest annual figure on record is $237.70M in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$188.27M-20.8%
FY2020Dec 31, 2020$237.70M+22.1%
FY2019Dec 31, 2019$194.63M+165.2%
FY2018Dec 31, 2018$73.38M+1944.5%
FY2012Dec 31, 2012$3.59M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$93.60M-49.9%
Q2 FY2022Jun 30, 2022$90.78M-51.0%
Q1 FY2022Mar 31, 2022$202.86M+10.3%
Q4 FY2021Dec 31, 2021$188.27M-20.8%
Q3 FY2021Sep 30, 2021$186.74M-21.2%
Q2 FY2021Jun 30, 2021$185.26M-24.0%
Q1 FY2021Mar 31, 2021$183.97M-24.4%
Q4 FY2020Dec 31, 2020$237.70M+22.1%
Q3 FY2020Sep 30, 2020$237.05M+22.0%
Q2 FY2020Jun 30, 2020$243.80M+25.6%
Q1 FY2020Mar 31, 2020$243.43M+231.2%
Q4 FY2019Dec 31, 2019$194.63M+165.2%
Q3 FY2019Sep 30, 2019$194.36M+165.3%
Q2 FY2019Jun 30, 2019$194.10M+165.4%
Q1 FY2019Mar 31, 2019$73.50M–
Q4 FY2018Dec 31, 2018$73.38M–
Q3 FY2018Sep 30, 2018$73.26M–
Q2 FY2018Jun 30, 2018$73.14M–

More TherapeuticsMD figures

See a number that looks wrong?